Research programme: anxiety and epilepsy therapeutics - Bionomics

Drug Profile

Research programme: anxiety and epilepsy therapeutics - Bionomics

Latest Information Update: 30 Jun 2009

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Bionomics
  • Class Small molecules
  • Mechanism of Action G protein-coupled receptor modulators; GABA A receptor agonists; Ion channel modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Anxiety disorders; Epilepsy

Most Recent Events

  • 30 Jun 2009 BNC 210 entered PhI development, profile split out
  • 10 Jul 2007 Preclinical development is ongoing
  • 02 Mar 2004 Preclinical trials in Anxiety disorders in Australia (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top